Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.30 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7550123 | 0.76 | L3MBTL1 (0.38) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL18792835 | 0.75 | EPHX1 (0.48) | ALOX5 | |
| SCHEMBL18792872 | 0.75 | EPHX1 (0.48) | ALOX5 | |
| SCHEMBL7051597 | 0.75 | SHBG (0.44) | — | |
| SCHEMBL18792871 | 0.75 | EPHX1 (0.48) | ALOX5 | |
| SCHEMBL658967 | 0.72 | — | — | |
| SCHEMBL22388295 | 0.72 | CTSK (0.36) | — | |
| SCHEMBL28654671 | 0.71 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9823595 | 0.70 | TP53 (0.36) | — | |
| SCHEMBL3812223 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970044-B1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AG (DE) | 2003-05-07 | — | — | EP | disclosed |
| US-6410486-B2 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-25 | — | — | US | disclosed |
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | WETTERICH FRANK (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6265447-B1 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-24 | — | — | US | disclosed |
| EP-0970044-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998041499-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | CBR3, CYCS, CBR1 | ALOX5 1957/4885GABRA1 1579/4885GABRA5 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.